Corvus Pharmaceuticals (CRVS) Non Operating Income (2025 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly Non Operating Income of $1.2 million for Q1 2026, down 95.28% year-over-year from $25.1 million in Q1 2025, and down 95.28% quarter-over-quarter from $25.1 million in Q1 2025.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Non Operating Income (2025 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Non Operating Income history runs 2 years deep, the most recent figure standing at $1.2 million for Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | -139.24 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -51.63 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Corvus Pharmaceuticals | 1.35 Bn | 1.14 Bn | - | 1.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 25.12 Mn |